Smartwatches could offer an objective measure of ADHD hyperactivity

NCT ID NCT05810636

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study explores whether wearable smartwatches can objectively measure activity levels in children with attention-deficit hyperactivity disorder (ADHD). Researchers plan to compare activity data from 50 children with ADHD and 50 neurotypical children over a one-month period. The goal is to see if wearable-measured acceleration correlates with standard behavioral questionnaires, potentially offering a new way to quantify hyperactivity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Garmin Vivosmart wearable device
What this could lead to: If successful, this could provide an objective, wearable-based tool to quantify hyperactivity in children with ADHD, potentially aiding diagnosis and monitoring.
What could go wrong: The study is observational and relatively small, so results may not generalize. Wearable data may not fully capture ADHD-related hyperactivity, and correlations with questionnaires could be weak.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY

Contacts and locations

Locations

National Taiwan University Hospital

Taipei, 10048, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.